|
1
|
Patel T: Increasing incidence and
mortality of primary intra-hepatic cholangiocarcinoma in the United
States. Hepatology. 33:1353–1357. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rizvi S and Gores GJ: Pathogenesis,
diagnosis, and management of cholangiocarcinoma. Gastroenterology.
145:1215–1229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shaib Y and El-Serag HB: The epidemiology
of cholangiocar-cinoma. Semin Liver Dis. 24:115–125. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pascher A, Jonas S and Neuhaus P:
Intrahepatic cholangiocar-cinoma: Indication for transplantation. J
Hepatobiliary Pancreat Surg. 10:282–287. 2003. View Article : Google Scholar
|
|
6
|
Kitamura K, Kangawa K, Kawamoto M, Ichiki
Y, Nakamura S, Matsuo H and Eto T: Adrenomedullin: A novel
hypotensive peptide isolated from human pheochromocytoma. Biochem
Biophys Res Commun. 192:553–560. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martínez A, Vos M, Guédez L, Kaur G, Chen
Z, Garayoa M, Pío R, Moody T, Stetler-Stevenson WG, Kleinman HK, et
al: The effects of adrenomedullin overexpression in breast tumor
cells. J Natl Cancer Inst. 94:1226–1237. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ramachandran V, Arumugam T, Hwang RF,
Greenson JK, Simeone DM and Logsdon CD: Adrenomedullin is expressed
in pancreatic cancer and stimulates cell proliferation and invasion
in an autocrine manner via the adrenomedullin receptor, ADMR.
Cancer Res. 67:2666–2675. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Berenguer C, Boudouresque F, Dussert C,
Daniel L, Muracciole X, Grino M, Rossi D, Mabrouk K,
Figarella-Branger D, Martin PM, et al: Adrenomedullin, an
autocrine/paracrine factor induced by androgen withdrawal,
stimulates ‘neuroendocrine phenotype’ in LNCaP prostate tumor
cells. Oncogene. 27:506–518. 2008. View Article : Google Scholar
|
|
10
|
Zhu HT, Dong QZ, Wang G, Zhou HJ, Ren N,
Jia HL, Ye QH and Qin LX: Identification of suitable reference
genes for qRT-PCR analysis of circulating microRNAs in hepatitis B
virus-infected patients. Mol Biotechnol. 50:49–56. 2012. View Article : Google Scholar
|
|
11
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Simon R, Mirlacher M and Sauter G: Tissue
microarrays. Biotechniques. 36:98–105. 2004.PubMed/NCBI
|
|
13
|
Zhou H, Huang H, Shi J, Zhao Y, Dong Q,
Jia H, Liu Y, Ye Q, Sun H, Zhu X, et al: Prognostic value of
interleukin 2 and interleukin 15 in peritumoral hepatic tissues for
patients with hepatitis B-related hepatocellular carcinoma after
curative resection. Gut. 59:1699–1708. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aggarwal G, Ramachandran V, Javeed N,
Arumugam T, Dutta S, Klee GG, Klee EW, Smyrk TC, Bamlet W, Han JJ,
et al: Adrenomedullin is up-regulated in patients with pancreatic
cancer and causes insulin resistance in β scells and mice.
Gastroenterology. 143:1510–1517. 2012. View Article : Google Scholar
|
|
15
|
Chen P, Huang Y, Bong R, Ding Y, Song N,
Wang X, Song X and Luo Y: Tumor-associated macrophages promote
angiogenesis and melanoma growth via adrenomedullin in a paracrine
and autocrine manner. Clin Cancer Res. 17:7230–7239. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rhim AD, Mirek ET, Aiello NM, Maitra A,
Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK,
Vonderheide RH, et al: EMT and dissemination precede pancreatic
tumor formation. Cell. 148:349–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ding W, You H, Dang H, LeBlanc F, Galicia
V, Lu SC, Stiles B and Rountree CB: Epithelial-to-mesenchymal
transition of murine liver tumor cells promotes invasion.
Hepatology. 52:945–953. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
El Khatib M, Kalnytska A, Palagani V,
Kossatz U, Manns MP, Malek NP, Wilkens L and Plentz RR: Inhibition
of hedgehog signaling attenuates carcinogenesis in vitro and
increases necrosis of cholangiocellular carcinoma. Hepatology.
57:1035–1045. 2013. View Article : Google Scholar
|
|
19
|
Oishi N, Kumar MR, Roessler S, Ji J,
Forgues M, Budhu A, Zhao X, Andersen JB, Ye QH, Jia HL, et al:
Transcriptomic profiling reveals hepatic stem-like gene signatures
and interplay of miR-200c and epithelial-mesenchymal transition in
intra-hepatic cholangiocarcinoma. Hepatology. 56:1792–1803. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park SC, Yoon JH, Lee JH, Yu SJ, Myung SJ,
Kim W, Gwak GY, Lee SH, Lee SM, Jang JJ, et al: Hypoxia-inducible
adreno-medullin accelerates hepatocellular carcinoma cell growth.
Cancer Lett. 271:314–322. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakata T, Seki N, Miwa S, Kobayashi A,
Soeda J, Nimura Y, Kawasaki S and Miyagawa S: Identification of
genes associated with multiple nodules in hepatocellular carcinoma
using cDNA microarray: Multicentric occurrence or intrahepatic
metastasis? Hepatogastroenterology. 55:865–872. 2008.PubMed/NCBI
|
|
22
|
Sánchez-Tilló E, Siles L, de Barrios O,
Cuatrecasas M, Vaquero EC, Castells A and Postigo A: Expanding
roles of ZEB factors in tumorigenesis and tumor progression. Am J
Cancer Res. 1:897–912. 2011.PubMed/NCBI
|
|
23
|
Joseph JV, Conroy S, Tomar T,
Eggens-Meijer E, Bhat K, Copray S, Walenkamp AM, Boddeke E,
Balasubramanyian V, Wagemakers M, et al: TGF-β is an inducer of
ZEB1-dependent mesenchymal transdifferentiation in glioblastoma
that is associated with tumor invasion. Cell Death Dis.
5:e14432014. View Article : Google Scholar
|
